Insights from 2023 SABCS
Playback speed
10 seconds
SABCS 2023 Insights: "A Study of RGT-419B, a Next-Gen CDK4 Inhibitor, in Pts With HR+/HER2- Advanced or Metastatic BC Who Progressed on Prior CDK4/6i"
By
Insights from 2023 SABCS
FEATURING
Seth Wander
By
Insights from 2023 SABCS
FEATURING
Seth Wander
165 views
January 3, 2024
Comments 0
Login to view comments.
Click here to Login
Videos